Trial Profile
Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Ultrasound Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jun 2017
Price :
$35
*
At a glance
- Drugs Perflutren (Primary)
- Indications Breast cancer
- Focus Diagnostic use
- 01 Jun 2016 Status changed from active, no longer recruiting to completed.
- 23 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 22 Jan 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018, as reported by ClinicalTrials.gov.